BIVRX
Price
$16.31
Change
-$0.11 (-0.67%)
Updated
Jul 18 closing price
Net Assets
923.71M
CPCLX
Price
$16.81
Change
-$0.04 (-0.24%)
Updated
Jul 18 closing price
Net Assets
1.13B
Interact to see
Advertisement

BIVRX vs CPCLX

Header iconBIVRX vs CPCLX Comparison
Open Charts BIVRX vs CPCLXBanner chart's image
Invenomic Investor
Price$16.31
Change-$0.11 (-0.67%)
VolumeN/A
Net Assets923.71M
Calamos Phineus Long/Short C
Price$16.81
Change-$0.04 (-0.24%)
VolumeN/A
Net Assets1.13B
BIVRX vs CPCLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BIVRX vs. CPCLX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVRX is a Buy and CPCLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CPCLX has more cash in the bank: 1.13B vs. BIVRX (924M). BIVRX pays higher dividends than CPCLX: BIVRX (3.66) vs CPCLX (2.85). BIVRX was incepted earlier than CPCLX: BIVRX (8 years) vs CPCLX (9 years). BIVRX (3.42) is less costly to investors than CPCLX (3.19). CPCLX is a more actively managed with annual turnover of: 342.00 vs. BIVRX (170.00). CPCLX has a lower initial minimum investment than BIVRX: CPCLX (2500) vs BIVRX (5000). CPCLX annual gain was more profitable for investors over the last year : 9.09 vs. BIVRX (-1.81). BIVRX return over 5 years is better than : 65.57 vs. CPCLX (55.12).
BIVRXCPCLXBIVRX / CPCLX
Total Expense Ratio3.423.19107%
Annual Report Gross Expense Ratio3.423.19107%
Fund Existence8 years9 years-
Gain YTD-3.18411.516-28%
Front LoadN/AN/A-
Min. Initial Investment50002500200%
Min. Initial Investment IRAN/AN/A-
Net Assets924M1.13B82%
Annual Yield % from dividends3.662.85128%
Returns for 1 year-1.819.09-20%
Returns for 3 years-25.4127.96-91%
Returns for 5 years65.5755.12119%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLVLY7.100.16
+2.38%
Clinuvel Pharmaceuticals Ltd.
CYAGF8.08N/A
N/A
Cyber Agent Inc.
KGSPF84.17N/A
N/A
Kingspan Group plc.
ATGPF14.35N/A
N/A
AltaGas Ltd.
FDCFF0.03N/A
-2.92%
Forum Energy Metals Corp.